Related references
Note: Only part of the references are listed.A conditional error function approach for adaptive enrichment designs with continuous endpoints
Marius Placzek et al.
STATISTICS IN MEDICINE (2019)
Mastering variation: variance components and personalised medicine
Stephen Senn
STATISTICS IN MEDICINE (2016)
Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion Diagnostics
Marilyn Tsourounis et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2015)
Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs
Alexandre Vivot et al.
GENETICS IN MEDICINE (2015)
A REGULATORY PERSPECTIVE ON ESSENTIAL CONSIDERATIONS IN DESIGN AND ANALYSIS OF SUBGROUPS WHEN CORRECTLY CLASSIFIED
Sue-Jane Wang et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2014)
The Regulation of Companion Diagnostics: A Global Perspective
Maham Ansari
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2013)
Pharmacogenomics Knowledge for Personalized Medicine
M. Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Adaptive seamless phase II/III designs - Background, operational aspects, and examples
Jeff Maca et al.
DRUG INFORMATION JOURNAL (2006)
Clinical biomarkers in drug discovery and development
R Frank et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Share Paper
